SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-23-021708
Filing Date
2023-06-09
Accepted
2023-06-09 16:12:31
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 xforforms-3june2023.htm S-3 291845
2 EX-FILING FEES ex107s-3june2023.htm EX-FILING FEES 23950
3 EX-5.1 ex51legalopinions-3june2023.htm EX-5.1 13665
4 EX-23.1 ex-231pwcconsentsx3q22023.htm EX-23.1 2159
5 GRAPHIC cooley.jpg GRAPHIC 11660
6 GRAPHIC image_0.jpg GRAPHIC 85
7 GRAPHIC image_1a.jpg GRAPHIC 8359
8 GRAPHIC image_5a.jpg GRAPHIC 3709
  Complete submission text file 0001628280-23-021708.txt   360647
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272551 | Film No.: 231005389
SIC: 2836 Biological Products, (No Diagnostic Substances)